PARP1 and cancer: Given these two diverging roles of PARP-1, the PARP inhibitors may be used to not only treat cancers but also to prevent cancers that form from the potentiation of inflammation/ROS-induced damage caused by persistent PARP-1 upregulation in response to DNA damage.